Healthcare for obstructive lung disease in an industrial spirometry surveillance program

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 3, 2009, Pages 336-342

  Gulati, Mridu ^a,b   Slade, Martin D ^a   Fiellin, Martha G ^a   Cullen, Mark R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SPIROMETRY;

EID: 63449127577     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181954ae6     Document Type: Article

References (40)

1. Hnizdo E, Sullivan P, Bang K. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002; 156:738- 746.
2. American Thoracic Society. Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787-797.
3. Coultas D, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national health sample of United States adults. Am J Respir Crit Care Med. 2001; 164:372- 377.
4. U.S. Code of Federal Regulations. Asbestos. Title 29, Part 1910.1001. U.S. Code of Federal Regulations; 1994.
5. U.S. Code of Federal Regulations. Coke Oven Emissions. Title 29, Part 1910.1029. U.S. Code of Federal Regulations; 1976.
6. U.S. Code of Federal Regulations. Cadmium. Title 29, Part 1910.1043. U.S. Code of Federal Regulations; 1985.
7. U.S. Code of Federal Regulations. Cotton Dust. Title 29, Part 1910.1043. U.S. Code of Federal Regulations; 1985.
8. 8.NIOSH Criteria Documents. Criteria for a Recommended Standard: Occupational Exposure to Respirable Coal Mine Dust. 1995.
9. Preventing Silicosis. NIOSHV/Department of Labor Fact Sheet; October 31,1996.
10. NIOSH. Hazard Alert: Prevention of Silicosis and Deaths from Silicosis from Sandblasting. DHHS (NIOSH Publ. No. 92-102); 1992.
11. NIOSH. Hazard Alert: Prevention of Silicosis and Deaths from Silicosis in Rock Drillers. DHHS (NIOSH Publ. No. 92- 107);1992.
12. NIOSH. Hazard Alert: Prevention of Silicosis and Deaths in Construction Workers. DHHS (NIOSH Publ. No. 96-112); 1992.
13. OSHA. National Emphasis Program Crystalline Silica. Available at: http://www.osha.gov/SLTC/silicacrystalline/ standards.html. Accessed August 1, 2008.
14. Townsend MC. ACOEM position statement. Spirometry in the occupational setting. American College of Occupational and Environmental Medicine. J Occup Enivron Med. 2000;42:228-245.
15. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of smoking cessation on 14.5-year mortality. Ann Intern Med. 2005;142: 233-239.
16. Anthonisen N, Connett J, Kiley J, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bron- chodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994; 272:1497-1505.
17. Hankinson J, Wagner G. Medical screening using periodic spirometry for detection of chronic lung disease. Occup Med. 1993;8:353-361.
18. Hankinson J. Pulmonary function testing in the screening of workers: guidelines for instrumentation, performance, and interpretation. J Occup Med. 1986;28: 1081-1092.
19. Harber P, Lockey J. Pulmonary function testing in pulmonary prevention. Occup Med. 1991;6:69-79.
20. Abramson MJ, Wlodarczyk JH, Saunders NA, Hensley MJ. Does aluminum smelting cause lung disease? Am Rev Resp Dis. 1989;139:1042-1057.
21. Kongerud J, Gronnesby J, Magnus P. Respiratory symptoms and lung function of aluminum potroom workers. Scand J Work Environ Health. 1990;16:270-277.
22. O'Donnell T, Welford B, Coleman E. Potroom asthma: New Zealand experience and follow up. Am J Ind Med. 2007;15:43-49.
23. Fritschi L, Sim R, Forbes A, et al. Respiratory symptoms and lung function in two prebake smelters. Am J Ind Med. 1999;35:491-498.
24. Kaltreider NL, Elder MJ, Cralley LV, Colwell MO. Health survey of aluminum workers with special reference to fluoride exposure. J Occup Med. 1982; 14:531 541.
25. Soyseth V, Boe J, Kongerud J. Relation between decline in FEV 1 and exposure to dust and tobacco smoke in aluminum potroom workers. Occup Environ Med. 1997;54:27-31.
26. Kongerud J, Samuelsen S. A longitudinal study of symptoms in aluminum potroom workers. Am Rev Respir Dis. 1991; 144: 10-16.
27. Radon K, Nowak D, Heinrich-Ramm R, Szadkowski D. Respiratory health and fluoride exposure in different parts of the modern primary aluminum industry. Int Arch Occup Environ Health. 1999:72: 297-303.
28. Fritschi L, Sim M, Forbes A, et al. Respiratory symptoms and lung-function changes with exposure to five substances in aluminium smelters. Int Arch Occup Environ Health. 2003;76:103-110.
29. Taiwo O, Sircar K, Slade M, et al. Incidence of asthma among aluminum workers. J Occup Environ Med. 2006;48:275- 282.
30. Public Health Service, U.S. Department of Health and Human Services. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, U.S. Department of Health and Human Services; 1988.
31. http://www.fda.gov/cder/ndc/database/.
32. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Resp Dis. 1991;144:1202-1218.
33. Soyseth V. Konegrud J. Prevalence of respiratory disorders among aluminum potroom workers in relation to exposure to fluoride. Br J Ind Med. 1992;49:125-130.
34. Sarlo K. Control of occupational asthma and allergy in the detergent industry. Ann Allergy Asthma Immunol. 2003;90(Suppl 2):32-34.
35. Schweigert M, Mackenzie D, Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy. 2000;30:1511-1518.
36. Charous B, Blanco C, Tarlo S, et al. Natural rubber latex allergy after 12 years: recommendations and perspectives. J Allergy Clin Immunol. 2002;109:31-34.
37. Bernstein D, Karnani R, Biagini R, et al. Clinical and occupational outcomes in healthcare workers with natural rubber latex allergy. Ann Allergy Asthma Immunol. 2003;90:209-213.
38. Tarlo S, Liss G, Yeung K. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med. 2002;59:58-62.
39. Barnes PJ. The size of the problem of managing asthma. Respir Med. 2004; (Suppl B):S4-S8.
40. Rabe K, Vermeire P, Soriano J, Maier W. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000; 16:802-807.